Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction
Publication
, Journal Article
Harrelson, L; Califf, RM; Lee, K
Published in: Controlled Clinical Trials
January 1, 1989
Duke Scholars
Published In
Controlled Clinical Trials
DOI
ISSN
0197-2456
Publication Date
January 1, 1989
Volume
10
Issue
3
Start / End Page
349
Related Subject Headings
- Public Health
- General Clinical Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrelson, L., Califf, R. M., & Lee, K. (1989). Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction. Controlled Clinical Trials, 10(3), 349. https://doi.org/10.1016/0197-2456(89)90173-6
Harrelson, L., R. M. Califf, and K. Lee. “Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction.” Controlled Clinical Trials 10, no. 3 (January 1, 1989): 349. https://doi.org/10.1016/0197-2456(89)90173-6.
Harrelson L, Califf RM, Lee K. Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction. Controlled Clinical Trials. 1989 Jan 1;10(3):349.
Harrelson, L., et al. “Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction.” Controlled Clinical Trials, vol. 10, no. 3, Jan. 1989, p. 349. Scopus, doi:10.1016/0197-2456(89)90173-6.
Harrelson L, Califf RM, Lee K. Use of ejection fraction as a surrogate endpoint for death in clinical trials of acute myocardial infraction. Controlled Clinical Trials. 1989 Jan 1;10(3):349.
Published In
Controlled Clinical Trials
DOI
ISSN
0197-2456
Publication Date
January 1, 1989
Volume
10
Issue
3
Start / End Page
349
Related Subject Headings
- Public Health
- General Clinical Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences